Little Oliver Osborn is unlikely to live past the age of seven unless the controversial treatment pays off The parents of a one year-old baby who suffers from a rare form of epilepsy are hoping a controversial new treatment using CANNABIS will help him. Little 10-month-old Oliver Osborn has migrating partial epilepsy which can leave children suffering up to 100 seizures a day. Victims rarely live beyond the age of seven but a new treatment from America using cannabis in liquid form, with 'high' ingredient removed, is offering a last-ditch hope. It has drastically reduced the amount of seizures in children - by up to 90% in some cases - and Oliver's parents say it could be the cure they need. SWNS Baby Oliver Osborn The alternative treatment is not yet available in the UK but Oliver's parents Rik Osborn and Danielle Coils, 28, are hoping fundraising efforts will help bring it here. Rik, 29, said: "Hopefully it could be a step forward. Read more: Baby with rare form of epilepsy could be cured using CANNABIS … Continue reading →

Contact Information Available for logged-in reporters only Newswise (NEW YORK May 29) The Icahn School of Medicine at Mount Sinai has joined Autism BrainNet, a new network of research institutions created to collect, store and distribute postmortem brain tissue resources that will help scientists gain a deeper understanding of the causes, treatment and cure of autism spectrum disorder, which now affects an estimated one in 68 children. Launched by the Simons Foundation and Autism Speaks, Autism BrainNet recently joined with the Autism Science Foundation to unveil the Autism BrainNet registration site, It Takes Brains. "In order for researchers to understand the fundamental genetic and neuropathological aspects of autism spectrum disorder, the study of brain tissue from individuals with autism spectrum disorder is essential, but there is a shortage of donated tissue, says Patrick R. Hof, MD, Vice-Chair for the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai and New York Node Director for Autism BrainNet. "While we know autism is a neurological disorder, the alterations in brain structure and function that account for this widespread and lifelong behavioral disorder remain unknown. Gaining this understanding will influence how we develop strategies for prevention and effective treatment. Previous … Continue reading →

The Woodlands, TX (PRWEB) May 29, 2014 During Stroke Awareness Month this May, Dr. Gayle Bradshaw is encouraging patients to reduce their risk of experiencing a stroke by scheduling an appointment for gum disease treatment in The Woodlands. Research has shown that people with gum disease have a heightened risk of stroke, and though the exact reason for the relationship is not known, people can benefit from eliminating this potential risk factor. Dr. Bradshaw offers patients various periodontal disease treatments that can address the condition and mitigate the health risks associated with it. Gum disease is a health condition that will affect many people at some point. The Centers for Disease Control and Prevention estimates almost half of adults over 30 have gum disease. The condition can raise the risk of various health problems, but stroke is one that is often overlooked. Unfortunately, research from the American Stroke Association indicates people with gum disease have more than four times the risk of stroke than those who do not have this oral infection. The conditions may be linked because periodontal disease allows harmful bacteria to enter the bloodstream, leading to inflammation throughout the body, which can raise the risk of other … Continue reading →

Most infectious pathogens have anecdotal evidence to support a link with stroke, but certain pathogens have more robust associations, in which causation is probable. Few dedicated prospective studies of stroke in the setting of infection have been done. The use of head imaging, a clinical standard of diagnostic care, to confirm stroke and stroke type is not universal. Data for stroke are scarce in locations where infections are probably most common, making it difficult to reach conclusions on how populations differ in terms of risk of infectious stroke. The treatment of infections and stroke, when concomitant, is based on almost no evidence and requires dedicated efforts to understand variations that might exist. We highlight the present knowledge and emphasise the need for stronger evidence to assist in the diagnosis, treatment, and secondary prevention of stroke in patients in whom an infectious cause for stroke is probable. See the original post: Infectious causes of stroke … Continue reading →